학술논문
A multicohort phase 2 trial of ADT, docetaxel plus nivolumab in patients with de novo metastatic hormone-sensitive prostate cancer enriched for inflamed tumors and DNA damage repair defects.
Document Type
Article
Author
Wei, Xiao X.; Xie, Wanling; Chahoud, Jad; Emamekhoo, Hamid; McKay, Rana R.; Marshall, Catherine Handy; Einstein, David Johnson; Lang, Joshua Michael; Raymond, Sarah; Roberts, Daniel Aaron; Sunkara, Rajitha; Ravi, Praful; Tewari, Alok; Pomerantz, Mark; Dong, Fei; Siegmund, Stephanie; Rodig, Scott J.; Pfaff, Kathleen L.; Sweeney, Christopher; Taplin, Mary-Ellen
Source
Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, pTPS244-TPS244, 235p
Subject
Language
ISSN
0732183X